Market Cap:
$ SEC Filings
Filing | Filed On |
---|---|
CURRENT REPORT | 14 Nov 2023 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 02 Nov 2023 |
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 02 Nov 2023 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 25 Oct 2023 |
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 25 Oct 2023 |
CURRENT REPORT | 19 Oct 2023 |
SHAREHOLDER JERALD HAMMANN DISCONTINUES DMK PHARMACEUTICALS CORP. PROXY CONTEST | 17 Oct 2023 |
CURRENT REPORT | 17 Oct 2023 |
DEFINITIVE PROXY STATEMENT | 12 Oct 2023 |
CURRENT REPORT | 10 Oct 2023 |
PRELIMINARY PROXY STATEMENT | 02 Oct 2023 |
AMENDMENT TO FORM SC 13D | 26 Sep 2023 |
FORM 4 - VERSI | 19 Sep 2023 |
CURRENT REPORT | 08 Sep 2023 |
CURRENT REPORT | 01 Sep 2023 |
CURRENT REPORT | 29 Aug 2023 |
CURRENT REPORT | 21 Aug 2023 |
QUARTERLY REPORT | 21 Aug 2023 |
NOTICE UNDER RULE 12B25 OF INABILITY TO TIMELY FILE | 14 Aug 2023 |
SCHEDULE 13G | 10 Aug 2023 |